These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical studies on 9,3"-diacetylmidecamycin in respiratory tract infections in pediatric field (author's transl)].
    Author: Aoyama R, Kakizaki Y, Ohnishi A, Izumi Y, Fujita M, Nagata K.
    Journal: Jpn J Antibiot; 1982 Apr; 35(4):919-22. PubMed ID: 6980296.
    Abstract:
    Clinical studies on 9,3"-diacetylmidecamycin (MOM) was carried out in 31 patients with respiratory tract infections (acute pharyngitis 6, acute purulent tonsillitis 5, scarlet fever 1, acute bronchitis 6, pneumonia 13 cases), in dose of 12 approximately 34 mg/kg divided 3 per day for 3 approximately 19 days. The overally efficacy rate was 74.2%. As to adverse reaction, exanthema and diarrhea with abdominal pain were observed in each 1 patient. Eosinophilia and elevation of serum GPT were noted in each 1 patient.
    [Abstract] [Full Text] [Related] [New Search]